Skip to main content

Table 3 Implant survival rate based on the univariate log-rank tests

From: Long-term survival of implant-based oral rehabilitation following maxillofacial reconstruction with vascularized bone flap

Variables

Classification

Patients (N)

Implants (N)

SR T1 (%)

SD

SR T2 (%)

SD

SR T5 (%)

SD

ST T5 (m)

SD

95% CI

P-value

Age

≥ 65

10

31

80.6

7.1

69.1

8.7

69.1

8.7

45.3

4.1

37.2

53.4

0.113

< 65

30

120

89.1

2.8

86.5

3.2

83.2

3.6

51.7

1.7

48.3

55.1

 

Gender

Male

26

100

89.0

3.1

85.7

3.5

83.3

3.8

51.6

1.9

47.9

55.4

0.233

Female

14

51

84.3

5.1

82.0

5.5

71.7

7.3

47.0

3.3

40.6

53.4

 

Smoking

Yes

26

100

85.0

3.6

74.2

4.6

72.5

4.8

46.8

2.3

42.3

51.3

0.004

No

14

51

98.0

1.9

94.1

3.3

94.1

3.3

57.0

1.7

53.6

60.3

 

Indication

Malignant tumor

22

83

88.0

3.6

81.6

4.3

78.1

4.8

49.2

2.3

44.6

53.8

0.335

Benign tumor or jaw cyst

5

16

93.8

6.1

93.8

6.1

93.8

6.1

57.3

2.7

52.0

62.5

 

ORN

9

38

76.1

7.0

76.1

7.0

76.1

7.0

48.2

3.5

41.4

55.1

 

Trauma

4

14

91.7

8.0

91.7

8.0

91.7

8.0

56.6

3.3

50.2

63.0

 

Site of implants

Mandible

35

130

86.2

3.0

80.0

3.6

78.9

3.7

49.6

1.8

46.0

53.2

0.257

Maxilla

5

21

95.2

4.6

89.6

7.0

89.6

7.0

55.7

2.9

50.1

61.3

 

Flap type

VFF

31

131

86.3

3.0

79.5

3.6

78.5

3.7

49.4

1.8

45.9

53.0

0.133

VIF/VOSF

9

20

95.0

4.9

95.0

4.9

95.0

4.9

35.0

1.0

33.1

36.9

 

IF

Received

15

53

75.3

5.9

66.7

6.7

66.7

6.7

43.2

3.4

36.6

49.8

0.001

Not received

25

98

93.9

2.4

89.0

3.3

87.6

3.5

54.3

1.6

51.1

57.5

 

DIIS

I stage

10

35

80.0

6.8

66.1

8.5

66.1

8.5

52.5

1.7

49.1

55.8

0.019

II stage

30

116

90.5

2.7

85.4

3.4

84.2

3.6

43.0

4.2

34.7

51.3

 

Oral hygiene

Good

27

110

96.4

1.8

95.3

2.1

93.9

2.4

57.2

1.1

55.0

59.4

0.000

Poor

13

41

65.9

7.4

45.8

7.8

45.8

7.8

33.1

4.0

25.3

40.8

 

Flap complication

Present

12

45

82.2

5.7

71.1

6.8

71.1

6.8

45.6

3.4

38.9

52.2

0.057

Absent

28

106

90.6

2.8

85.6

3.6

84.0

3.9

52.4

1.8

48.9

56.0

 

Implant location

Grafted bone

32

133

87.2

2.9

79.5

3.6

79.5

3.6

49.9

1.8

46.4

53.4

0.382

Native bone

8

18

94.4

5.4

94.4

5.4

86.6

9.0

54.6

3.6

47.4

61.7

 

Systemic disease

Present

8

34

82.4

6.5

68.9

8.2

68.9

8.2

44.5

4.1

36.4

52.6

0.052

Absent

32

117

89.7

2.8

84.9

3.4

83.7

3.6

52.2

1.7

48.8

55.5

 

Implant length

> 8 mm

34

122

88.5

2.9

82.7

3.5

81.5

3.7

50.9

1.8

47.4

54.5

0.484

≤ 8 mm

6

29

86.2

6.4

75.6

8.0

75.6

8.0

48.3

3.9

40.7

55.9

 
  1. SR T1 survival rate in the first year, SR T2 survival rate in the second year, SR T5 survival rate in the fifth year, ST T5 survival time over the 5 years, SD standardized error, IF irradiated flap